Bumper Offer - Urjas oil Just @ Rs. 1
Levosole-PP is an allopathic medicine The correct dosage of Levosole-PP depends on the patient's age, gender, and medical history. This information has been provided in detail in the dosage section.
Levosole-PP is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
Based on research, the following side effects have been observed when Levosole-PP is used -
Moderate
Mild
Is the use of Levosole-PP safe for pregnant women?
Levosole-PP may cause moderate side effects during pregnancy. If you feel its harmful effects, then stop taking this drug immediately, and do not take Levosole-PP again without your doctor's advice.
Is the use of Levosole-PP safe during breastfeeding?
Levosole-PP may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Levosole-PP, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Levosole-PP.
What is the effect of Levosole-PP on the Kidneys?
Levosole-PP rarely harms the kidneys.
What is the effect of Levosole-PP on the Liver?
Levosole-PP has very mild side effects on the liver.
What is the effect of Levosole-PP on the Heart?
The heart can be affected by Levosole-PP. If you experience any unwanted effects of this drug, stop taking it and consult your doctor. You should restart the medicine only after medical advice.
Levosole-PP should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Levosole-PP unless your doctor advises you to do so -
Is this Levosole-PP habit forming or addictive?
Forming a habit of Levosole-PP has not been reported.
Interaction between Food and Levosole-PP
There isn't any research available on the side effects of taking Levosole-PP with food.
Interaction between Alcohol and Levosole-PP
It is difficult to say anything about the effect of Levosole-PP and alcohol. No research has been done on this yet.
Levosole-PP is a bronchodilator which causes widening of bronchial smooth muscles present in the lungs which get tightened causing a constriction. Due to the constriction, the air cannot pass in and out of your lungs, and the relaxation of these bronchial muscles results in dilation of airways. This helps the patients breathe more easily which provides relief to the patient from the symptoms such as wheezing, and chest tightness.
No, Levosole-PP should not be discontinued without doctors advice. You are advised to always consult a doctor before discontinuing this medicine.
No, Levosole-PP does not cause weight gain. It has not been reported by the patients who are taking this drug. If you are experiencing rapid weight gain after taking this drug, then it might be due to some other reason and you are advised to discuss it with your doctor.
Yes, Levosole-PP is a bronchodilator. It is a short-acting bronchodilator which dilates the bronchi and bronchioles.
Yes, Levosole-PP may cause rapid heartbeats (tachycardia). It is a rare side effect of this drug. Tachycardia occurs because this drug sometimes stimulates the smooth muscles which are present in the heart. If you are experiencing rapid or increased heartbeats after taking this drug, then you are advised to consult your doctor without further delay.
This medicine data has been created by -
B.Pharma, Pharmacy
7 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Xopenex® (levalbuterol hydrochloride)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 763-765
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 705
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 116
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Atrovent® HFA (ipratropium bromide HFA)
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Ipravent® (ipratropium bromide)